EUVIMEDEUVIMED entdecken
Crossref

On Organic‐Molecule and Peptide Non‐Covalent Inhibitors of the TP53‐MDM2/MDMX Interaction: An Inside View From the Interaction Energy at Residue‐to‐Residue Level

Francesco Pietra iD

ChemMedChem · 28.10.2026 · 21 (20)

DOI: 10.1002/cmdc.70477 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, online erschienen am 21.10.2026. Verfasst von Francesco Pietra. Beteiligte Einrichtung: Classe di Scienze, Accademia Lucchese di Scienze, Lettere e Arti, Lucca, Italy. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-mdm2, Tumor Suppressor Protein p53, Peptides, Proto-Oncogene Proteins. Die Arbeit nennt 39 Literaturangaben. Gefördert von: C INECA-ISCRA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Depletion of the tumor‐suppressor TP53 is known to open the door to cancer and, after 30 years of research, no remedy has been approved. When TP53 depletion is due to trapping by MDM2, a key requisite for non‐covalent inhibitors is high affinity for MDM2 (and also for the MDMX analog, which plays an indirect role in depleting TP53). While inhibitor performance has always been measured by the binding energy, the present work offers a deeper view by evaluating the interaction energy and its electrostatic and vdW components at residue‐to‐residue level. In the absence of suitable experimental methods, the task was addressed using unrestricted MD and QM‐MM, including all inhibitors that are currently in clinical trials, and for which the static structure at high resolution has been made available. It has emerged, in the framework of weak, dispersion‐driven interactions that rarely exceed 6 kcal/mol, and with water solvation playing a major role, where the inhibitors bind better and where repulsions arise. In this scenario, a better pattern of interaction energies emerged with stabilized peptides than with organic‐molecule inhibitors. All that should help designing the next generation of inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-mdm2Tumor Suppressor Protein p53PeptidesProto-Oncogene ProteinsNuclear ProteinsHumansProtein BindingThermodynamicsCell Cycle ProteinsMolecular Dynamics SimulationMolecular Structure

Stichwörter der Autor:innen

MD/QM‐MM simulationsMDM2/MDMXTP53 cancers

Substanzen

Proto-Oncogene Proteins c-mdm2Tumor Suppressor Protein p53PeptidesMDM2 protein, humanCell Cycle ProteinsMDM4 protein, humanProto-Oncogene ProteinsTP53 protein, humanNuclear Proteins

Autor:innen und Institutionen

  • Classe di Scienze, Accademia Lucchese di Scienze, Lettere e Arti, Lucca, Italy.

ORCID-Profile: Francesco Pietra

Förderung

  • C INECA-ISCRA

Zitieren

APA

Pietra, F. (2026). On Organic‐Molecule and Peptide Non‐Covalent Inhibitors of the TP53‐MDM2/MDMX Interaction: An Inside View From the Interaction Energy at Residue‐to‐Residue Level. ChemMedChem, 21(20). https://doi.org/10.1002/cmdc.70477

Vancouver

Pietra F. On Organic‐Molecule and Peptide Non‐Covalent Inhibitors of the TP53‐MDM2/MDMX Interaction: An Inside View From the Interaction Energy at Residue‐to‐Residue Level. ChemMedChem. 2026;21(20). doi:10.1002/cmdc.70477

BibTeX
@article{Pietra2026,
  author = {Pietra, Francesco},
  title = {On Organic‐Molecule and Peptide Non‐Covalent Inhibitors of the TP53‐MDM2/MDMX Interaction: An Inside View From the Interaction Energy at Residue‐to‐Residue Level},
  journal = {ChemMedChem},
  year = {2026},
  volume = {21},
  number = {20},
  doi = {10.1002/cmdc.70477}
}
Kostenlos starten →